Litcius/Paper detail

Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients

Federica Zavaglio, Davide Vitello, Federica Bergami, Francesca Arena, Oscar Borsani, A. Colombo, Daniela Caldera, Daniele Lilleri, Irene Cassaniti, Paolo Bernasconi, Fausto Baldanti

2023Journal of Clinical Virology12 citationsDOI

Topics & Concepts

Human cytomegalovirusMedicineImmunologyELISPOTDiscontinuationCytomegalovirusHematopoietic stem cell transplantationStem cellImmune systemT cellVirologyTransplantationInternal medicineHerpesviridaeVirusViral diseaseBiologyGeneticsCytomegalovirus and herpesvirus researchImmunodeficiency and Autoimmune DisordersBiological Research and Disease Studies
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients | Litcius